Drug Watch: Agents in late-stage development for the treatment of types 1 and 2 diabetes mellitus (September 2008)
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Survey: Part B Price Negotiation Could have Significant Impact on Providers
Read More
Diabetes Management & Telehealth with Leslie Kolb
Listen
Big Beautiful Bill Reduces Drugs Eligible for Price Negotiations
ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain
Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer’s
Teva Launches First Generic GLP-1 Drug for Obesity